Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry

Share :
Published: 10 Oct 2016
Views: 2366
Dr Simon Chowdhury - Guy's Hospital, London, UK

Dr Chowdhury talks to ecancertv at ESMO 2016 about the Cancer Registry, that monitors the treatments and outcomes of over 3,000 patients across Europe with metastatic castration-resistant prostate cancer (mCRPC).

Dr Chowdhury also spoke with ecancer about fatigue among mCRPC patients treated with enzalutamide here.